| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5734643 | Surgery | 2017 | 8 Pages |
Abstract
Cytology+Â without noncurative factors was a predictive factor for a poor prognosis. Therefore, it is important to regard patients with pancreatic cancer characterized by cytology+Â as a special group that may warrant more aggressive adjuvant therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Toshiya MD, Kenoki MD, PhD, Sho MD, Fumihiko CT, Yasuhisa MD, PhD, Kohei MD, PhD, Yoshihiro MD, PhD, Tatsuya MD, PhD, Takao MD, PhD, Eishi MD, PhD, Yoshinao MD, PhD, Masafumi MD, PhD,